Calcipotriene: all 71 studies that test it

Page 1 of 1. Open to participants first (7), then studies with results posted, then the rest; newest registration first within each.

• A Prospective, Interventional, Exploratory Study Evaluating the Efficacy of Small-Molecule Compound XJH05 Ointment in the Treatment of Plaque PsoriasisRecruitingNCT07780929Not applicable
• Comparison of Topical Calcipotriol and Intralesional Steroids in Alopecia AreataNot yet recruitingNCT07453238Phase 4
• Utilization of a Microdevice for Psoriasis and Atopic DermatitisNot yet recruitingNCT07352566Phase 4
• COMPARISON OF EFFICACY AND SAFETY OF NARROWBAND UVB WITH 0.1% TACROLIMUS VS NARROWBAND UVB WITH 0.005% CALCIPOTRIOL IN TREATMENT OF VITILIGOEnrolling by invitationNCT06880042Early Phase 1
• A Pilot Clinical Trial Comparing Topical Fluorouracil to Fluorouracil Plus Calcipotriene Field Treatments in Patients With Multiple Actinic KeratosesRecruitingNCT06851507Phase 3
• Efficacy of Topical 5-Fluorouracil Vs Calcipotriol As Photodynamic Therapy Pre-treatment for Field Actinic KeratosesNot yet recruitingNCT06685588Not applicable
• Intralesional 5-Fluorouracil (5FU), Topical Calcipotriene Treatment for SCCRecruitingNCT03370406Phase 1
• A Study to Investigate Efficacy and Safety With LEO 90100 Compared With Daivobet® Ointment in Adult Chinese Subjects With Stable Plaque PsoriasisCompletedNCT05919082Phase 3Results posted
• A Study Evaluating the Efficacy and Tolerability of Enstilar Foam in Patients With Nail PsoriasisCompletedNCT04227288Phase 4Results posted
• A Maximal Use Trial Evaluating the Pharmacokinetic Profile of MC2-01 Cream in Adolescent SubjectsTerminatedNCT03819218Phase 2Results posted
• This Trial is a Randomised, Multicentre, Investigator-blind, Vehicle and Comparator-controlled, Parallel-group Trial With the Purpose of Evaluation Efficacy, Safety and Convenience of the MC2-01 CreamCompletedNCT03802344Phase 3Results posted
• Evaluation of the Vasoconstriction Properties of MC2-01 CreamCompletedNCT03758365Phase 1Results posted
• A Maximal Use Trial Evaluating the Pharmacokinetic Profile of MC2-01 CreamCompletedNCT03462927Phase 2Results posted
• A Clinical Trial Evaluating Efficacy and Safety of MC2-01 CreamCompletedNCT03308799Phase 3Results posted
• Adherence in Topical Treatment of PsoriasisCompletedNCT02858713Phase 4Results posted
• Molecular Effects of Topical Calcipotriene on MorpheaTerminatedNCT02411643Early Phase 1Results posted
• Safety and Efficacy of Once Daily Topical Treatment With LEO 90100 Aerosol Foam in Adolescent Subjects With Plaque PsoriasisCompletedNCT02387853Phase 2Results posted
• LEO 90100 Compared to Vehicle in Subjects With Psoriasis VulgarisCompletedNCT01866163Phase 3Results posted
• Olux E Foam and Sorilux Foam Combination Therapy for the Maintenance of Treatment Response in Patients With Moderate Plaque PsoriasisCompletedNCT01745133Phase 4Results posted
• "Clinical Trial to Determine the Efficacy of Vitamin D for Acne Therapy"CompletedNCT01694433Phase 2/3Results posted
• Effect of LEO 90100 on the HPA Axis and Calcium Metabolism in Subjects With Extensive Psoriasis VulgarisExtensive Psoriasis VulgarisCompletedNCT01600222Phase 2Results posted
• LEO 90100 in the Treatment of Psoriasis VulgarisCompletedNCT01536938Phase 2Results posted
• LEO 90100 Compared With Calcipotriol Plus Betamethasone Dipropionate Ointment, LEO 90100 Vehicle and Ointment Vehicle in Subjects With Psoriasis VulgarisCompletedNCT01536886Phase 2Results posted
• LEO 80185 in the Treatment of Psoriasis Vulgaris on the Non-scalp Regions of the Body (Trunk and/or Limbs)CompletedNCT01188928Phase 3Results posted
• A Psoriasis Plaque Test With LEO 29102 Cream and Its Combination ProductsCompletedNCT00875277Phase 2Results posted
• Safety and Efficacy of TACLONEX Ointment in Adolescent Patients (Aged 12 to 17 Years) With Psoriasis VulgarisCompletedNCT00817219Phase 2Results posted
• Effect of Calcipotriol Plus Hydrocortisone Ointment on the Adrenal Hormone Balance and Calcium Metabolism in Patients With Psoriasis Vulgaris on the Face and Skin FoldsCompletedNCT00704262Phase 2Results posted
• Efficacy and Safety of Calcipotriol Plus Hydrocortisone Ointment in Psoriasis Vulgaris on the Face and Skin FoldsCompletedNCT00691002Phase 3Results posted
• Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel Compared With Tacalcitol Ointment and the Gel Vehicle Alone in Patients With Psoriasis VulgarisCompletedNCT00670241Phase 3Results posted
• Efficacy and Safety of Calcipotriol Plus Hydrocortisone Ointment Compared With Tacalcitol Ointment in Patients With Psoriasis on the Face and Skin FoldsCompletedNCT00640822Phase 3Results posted
• Effect of Topical Calcipotriene/Betamethasone (Taclonex) in Managing Localized Breakthrough in Moderate to Severe Plaque Psoriasis in Patients Receiving Efalizumab (Raptiva)TerminatedNCT00608777Phase 4Results posted
• Adalimumab in Combination With Topical Treatment (Calcipotriol/Betamethasone) in Subjects With Moderate to Severe Psoriasis and Insufficient Response to Classic Systemic TreatmentCompletedNCT00574249Phase 3Results posted
• Topical Calcipotriol Versus Photodynamic Therapy in the Treatment of Oral LeukoplakiaActive, not recruitingNCT07658508Phase 2/3
• A Phase III Trial To Evaluate The Efficacy And Safety Of MC2-01 Cream Compared To CAL/BDP Gel and Vehicle In Plaque Psoriasis SubjectsCompletedNCT07357831Phase 3
• Evaluation of the Effect of Topical Calcipotriol Versus Platelet-Rich PlasmaCompletedNCT05954104Not applicable
• Testing the Efficacy of Topical Calcipotriene Plus 5-Fluorouracil Combination to Activate the Immune System Against Precancerous Skin Lesions in Organ Transplant RecipientsActive, not recruitingNCT05699603Phase 2
• Efficacy and Safety of Novel Formulations of Topical Calcipotriol in Patients With Mild to Moderate Plaque PsoriasisCompletedNCT05488990Phase 1/2
• Calcipotriol as a Novel Treatment for Central Centrifugal Cicatricial Alopecia (CCCA)WithdrawnNCT05416320Early Phase 1
• Efficacy and Safety of Sorilux in Maintenance Treatment of Moderate Type Plaque PsoriasisStatus unknownNCT04571151Phase 4
• The Maintenance Effect of Enstilar Foam in Combination With OtezlaStatus unknownNCT04555707Phase 4
• Turmeric Based Therapy in the Treatment of Psoriasis: A Clinical TrialStatus unknownNCT04071106Phase 2/3
• Combination Topical Therapy for Treatment of Scalp Actinic KeratosesTerminatedNCT03996252Early Phase 1
• Clinical Trial to Assess Safety, Tolerability and the Pharmacodynamics Effect of Calcipotriol/Betamethasone Dipropionate in a New Administration Form in Subjects With Chronic Plaque Psoriasis.CompletedNCT03898583Phase 1
• Topical Calcipotriol Versus Narrowband Ultraviolet B in Treatment of Alopecia AreataCompletedNCT03847441Not applicable
• Topical Calcipotriene Treatment for Breast Cancer ImmunopreventionTerminatedNCT03596073Phase 1
• To Study Generic Calcipotriene and Betamethasone Dipropionate Topical Suspension, 0.005%/0.064%, in the Treatment of Scalp PsoriasisCompletedNCT03331523Phase 3
• The Effect of Fractional Co2 Laser Either With Tacrolimus, Calcipotriol or NB-UVB in Stable Generalized VitiligoStatus unknownNCT03234673Phase 1
• BE Study of Calcipotriene Hydrate and Betamethasone Dipropionate Topical Suspension in the Treatment of Scalp PsoriasisCompletedNCT03122353Phase 1
• Topical Vitamin D in Acute Graft Versus Host Disease of the SkinCompletedNCT03093805Not applicable
• Efficacy of Topical Calcipotriol-assisted AFL-PDT in Actinic KeratosisCompletedNCT02976727Phase 1
• Comparative Effectiveness Trial in the Treatment of Pediatric Plaque MorpheaWithdrawnNCT02680717Phase 1
• Actinic Keratosis StudyCompletedNCT02019355Early Phase 1
• Study for Treatment With Calcipotriol/Betamethasone Dipropionate Gel in Korean Patients With Psoriasis VulgarisCompletedNCT02004574Phase 4
• Combined Cumulative Irritation Potential and Repeat Insult Patch Test of LEO 90100CompletedNCT01935869Phase 1
• Nicotinamide in the Treatment of PsoriasisCompletedNCT01763424Phase 2/3
• Evaluate Safety and Tolerability of Calcipotriene Foam 0.005% in Pediatric Subjects With Mild/Moderate Plaque PsoriasisCompletedNCT01582932Phase 1
• Safety, Tolerability, PD & PK of Calcipotriene 0.005% Foam, Under Maximal Use in 12-16 Year Olds With Plaque PsoriasisCompletedNCT01563068Phase 1
• An Exploratory Psoriasis Plaque Test Study With LEO 29102 Plus Calcipotriol, Ointment, in Psoriasis VulgarisCompletedNCT01466478Phase 1
• Nickel Desensitization Using Topical TherapyStatus unknownNCT01413477Not applicable
• A Psoriasis Plaque Test on LEO 27989 Ointment and Calcipotriol Plus LEO 27989 Ointment in Patients With Psoriasis VulgarisCompletedNCT01297166Phase 1
• The Role of Calcipotriol as Radioprotector of SkinStatus unknownNCT00445250Phase 2
• A Study of Sequential Treatment With Daivobet (Betamethasone Dipropionate Plus Calcipotriol) and Daivonex (Calcipotriol) in Patients With Psoriasis.CompletedNCT00437619Phase 4
• Efficacy, Safety, Preference and Response Duration of Clobex® Spray and Taclonex® Ointment in PsoriasisCompletedNCT00437255Phase 4
• Efficacy and Safety of Calcipotriene/Betamethasone Gel/Ointment in PsoriasisCompletedNCT00279162Phase 3
• Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel in Psoriasis VulgarisCompletedNCT00263718Phase 2
• Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Ointment in Patients With Psoriasis VulgarisCompletedNCT00248456Phase 4
• Efficacy of Calcipotriol Plus Betamethasone Gel Versus Calcipotriol Scalp Solution in Scalp PsoriasisCompletedNCT00243464Phase 3
• Efficacy and Safety of Calcipotriol Cream and (Calcipotriol + Betamethasone Dipropionate) Ointment in Psoriasis VulgarisCompletedNCT00216892Phase 4
• Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel for up to a Year in Scalp PsoriasisCompletedNCT00216879Phase 3
• Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel in Scalp PsoriasisCompletedNCT00216840Phase 3
• Efficacy and Safety of Calcipotriol Plus Betamethasone Gel in the Treatment of Scalp PsoriasisCompletedNCT00216827Phase 3

← Calcipotriene overview